Lumeris Appoints Dr. Charles Saunders as Chief Clinical Transformation Officer to Enhance Value-Based Care

Lumeris Welcomes Dr. Charles Saunders as Chief Clinical Transformation Officer

In a significant development for the healthcare technology sector, Lumeris has recently appointed Dr. Charles "Chuck" Saunders as its Chief Clinical Transformation Officer and President of Value-Based Care Enablement. This move is expected to accelerate the growth of value-based care models while enhancing the implementation of Lumeris' innovative AI-powered Tom™ platform across various healthcare organizations.

A Leader in Value-Based Care

Dr. Saunders brings a wealth of knowledge and experience to his new role at Lumeris, having spent over 30 years in clinical medicine, population health, and healthcare technology. His most recent position was as CEO of Integra Connect, a company concentrating on value-based care and precision medicine in oncology. Additionally, he played a pivotal role in establishing and leading Healthagen, Aetna's initiative in population health management that supported over 70 accountable care organizations.

As Chief Clinical Transformation Officer, Dr. Saunders will focus on improving clinical and financial outcomes within healthcare systems and among physicians operating under value-based care arrangements. His dual responsibility also involves providing clinical leadership to drive the adoption of Lumeris’ cutting-edge Tom™ platform, which integrates AI technology into primary care, facilitating smarter clinical decisions and more efficient healthcare delivery.

Advancing Healthcare Together

The integration of advanced AI capabilities with Lumeris’ deep expertise in value-based care paves the way for healthcare providers to confront increasing capacity challenges and lessen the administrative load. Dr. Saunders emphasized the importance of harnessing these tools to deliver more proactive and coordinated care to patients, which is essential in today’s dynamic healthcare environment.

Mike Long, the chairman and CEO of Lumeris, expressed his enthusiasm for Dr. Saunders' appointment, stating, "Chuck has spent his career at the intersection of clinical care, technology, and healthcare transformation, and few leaders are as knowledgeable about value-based care as he is." This recognition sets a promising tone for the future direction of Lumeris under his leadership.

Vision for the Future

Commenting on his new role, Dr. Saunders noted, “Lumeris has built a powerful combination of deep expertise in value-based care and robust health system partnerships with advanced AI capabilities. The opportunity now is to create synergies that help providers operate more efficiently and gain better insights for patient care decisions. This will enhance patient engagement in managing their health, enabling higher performance in value-based care models.”

Dr. Saunders earned his medical degree from the prestigious Johns Hopkins University and holds a bachelor’s degree in biological sciences from the University of Southern California. His academic credentials and extensive professional background Position him for success in his new role.

About Lumeris

Founded in 2010 and headquartered in St. Louis, Lumeris is dedicated to transforming primary care and advancing value-based care. The company utilizes a blend of technology, data, and care delivery expertise to empower healthcare systems and physician organizations to manage populations effectively and boost their clinical and financial performance. A core component of this mission is its AI-powered Tom™ platform, which enhances clinical workflows, expands patient access, and curtails administrative strains, thereby enabling more personalized and proactive care.

With more than 1,200 professionals, including engineers, clinicians, and healthcare specialists, Lumeris aims to innovate in the healthcare sector, enhancing the quality of care and improving overall patient satisfaction. As Dr. Saunders takes the helm of his new responsibilities, the healthcare community watches closely to see how these initiatives will unfold in the evolving landscape of value-based care.